
    
      Inclusion criteria

        1. pathologically confirmed BL or BL-U by World Health Organization 2008 criteria

        2. age >20 yrs

        3. received rituximab+chemotherapy as first-line treatment

        4. with measurable or evaluable lesion

        5. with complete set of clinical and laboratory data for the analysis
    
  